LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 42.45 | 17.25 | 2307 | 3504 | 0.6584 | 0.8939 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 44.42 | 17.25 | 590 | 3895 | 0.1515 | 0.5711 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 44.42 | 17.25 | 2184 | 3895 | 0.5606 | 0.8573 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 44.42 | 17.25 | 1719 | 3895 | 0.4413 | 0.8013 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 44.42 | 17.25 | 2487 | 3895 | 0.6384 | 0.8884 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.39 | 17.25 | 602 | 4141 | 0.1454 | 0.5671 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.39 | 17.25 | 2358 | 4141 | 0.5694 | 0.8625 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.39 | 17.25 | 1966 | 4141 | 0.4747 | 0.8202 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.39 | 17.25 | 2693 | 4141 | 0.6502 | 0.8940 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 48.36 | 17.25 | 948 | 4390 | 0.2159 | 0.6509 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 48.36 | 17.25 | 2518 | 4390 | 0.5735 | 0.8656 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 48.36 | 17.25 | 2478 | 4390 | 0.5644 | 0.8619 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 48.36 | 17.25 | 2879 | 4390 | 0.6558 | 0.8971 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 50.33 | 17.25 | 1293 | 4651 | 0.2780 | 0.7068 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 50.33 | 17.25 | 2622 | 4651 | 0.5637 | 0.8630 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 50.33 | 17.25 | 2357 | 4651 | 0.5068 | 0.8385 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 50.33 | 17.25 | 3040 | 4651 | 0.6536 | 0.8974 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 52.30 | 17.25 | 999 | 4798 | 0.2082 | 0.6485 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 52.30 | 17.25 | 2780 | 4798 | 0.5793 | 0.8700 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 52.30 | 17.25 | 2551 | 4798 | 0.5316 | 0.8503 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 52.30 | 17.25 | 3234 | 4798 | 0.6740 | 0.9051 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 54.27 | 17.25 | 1280 | 4884 | 0.2621 | 0.6968 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 54.27 | 17.25 | 2953 | 4884 | 0.6046 | 0.8802 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 54.27 | 17.25 | 2588 | 4884 | 0.5299 | 0.8500 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 54.27 | 17.25 | 3401 | 4884 | 0.6964 | 0.9131 | MN20160310_N02 | F04 |